concept

GLIA

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about GLIA: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

25Connections
30Hypotheses
30Analyses
2Outgoing
7Incoming

No summary available yet. View on Wiki →

💡 Concept Info
NameGLIA
Related DiseasesNEURODEGENERATIVE DISORDERS
Linked Hypotheses80 hypotheses

Wiki Pages (20)

Knowledge base pages for this entity

cbs-psp-daily-action-plan

therapeutic · 30834 words

Progressive Supranuclear Palsy (PSP)

disease · 12907 words

Corticobasal Syndrome (CBS)

disease · 11374 words

Microglia CD8+ T Cell Recruitment -- Supplementary WW Content

mechanism · 7227 words

calcium-dysregulation-comparison

mechanism · 6468 words

Pathway Diagram

graph TD
    GLIA["GLIA"]
    GLIA -->|"involved_in"| Neuronal_Function["Neuronal Function"]
    GLIA -->|"interacts"| inhibitory_neurons["inhibitory neurons"]
    GLIA -->|"involved_in"| Alzheimer_s_Disease["Alzheimer's Disease"]
    GLIA -->|"contributes to"| Motor_Neuron_Loss["Motor Neuron Loss"]
    GLIA -->|"modulates"| Neurodegeneration["Neurodegeneration"]
    GLIA -->|"mediates"| Ferroptosis["Ferroptosis"]
    Motor_Neurons["Motor Neurons"] -->|"interacts"| GLIA
    Sphingosine_1_Phosphate["Sphingosine-1-Phosphate"] -->|"expressed in"| GLIA
    APOE4["APOE4"] -->|"expressed in"| GLIA
    regulatory_modules["regulatory modules"] -->|"expressed in"| GLIA

Outgoing (18)

TargetRelationTypeStr
NEURONSinteracts_withcell_type0.80
NEURODEGENERATIVE DISORDERStargetsdisease0.80

Incoming (7)

SourceRelationTypeStr
Vlcfaassociated_withcompound0.90
Motor Neuronsinteracts_withcell_type0.90
Sphingosine-1-Phosphateexpressed_incompound0.85
ALZHEIMER'S DISEASEassociated_withdisease0.85
PARKINSON'S DISEASEassociated_withdisease0.85

Targeting Hypotheses (30)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
TREM2-Dependent Microglial Senescence Transition 0.692 neurodegeneration Gene expression changes in aging mouse b
ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro 0.662 Alzheimer's Disease Cell type vulnerability in Alzheimers Di
TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegen 0.639 neurodegeneration Gene expression changes in aging mouse b
SASP-Driven Microglial Metabolic Reprogramming in Synaptic P 0.638 neurodegeneration Senolytic therapy for age-related neurod
TREM2-Dependent Microglial Phagocytosis Acts as a Strain Sel 0.636 neurodegeneration What are the specific molecular determin
IL-6 Trans-Signaling Blockade at the Oligodendrocyte-Microgl 0.632 neuroinflammation How do oligodendrocytes initiate neuroin
Microglial TREM2-SYK Pathway Enhancement 0.626 neurodegeneration Cell type vulnerability in Alzheimers Di
Prime Editing Precision Correction of APOE4 to APOE3 in Micr 0.622 neurodegeneration CRISPR-based therapeutic approaches for
TREM2-Mediated Astrocyte-Microglia Cross-Talk in Neurodegene 0.612 neurodegeneration Gene expression changes in aging mouse b
TREM2-ASM Crosstalk in Microglial Lysosomal Senescence 0.612 neurodegeneration Gene expression changes in aging mouse b
TREM2-Mediated Astrocyte-Microglia Crosstalk in Neurodegener 0.607 neurodegeneration Gene expression changes in aging mouse b
TREM2-Microglial Clearance Enhancement as Common Mechanism f 0.604 neurodegeneration Why do p300/CBP inhibitors reduce both A
Microglial AIM2 Inflammasome as the Primary Driver of TDP-43 0.601 neurodegeneration What are the mechanisms by which gut mic
SIRT1-Mediated Reversal of TREM2-Dependent Microglial Senesc 0.600 neurodegeneration Gene expression changes in aging mouse b
C3aR Blockade Disrupts the Microglial-Astrocyte Feedforward 0.596 neuroinflammation What molecular mechanisms determine whet
TREM2-CSF1R Cross-Talk in Microglial Metabolic Reprogramming 0.589 neurodegeneration Gene expression changes in aging mouse b
H1: TREM2 Agonism to Redirect APOE4-Enhanced Microglia from 0.588 neurodegeneration How does APOE4's beneficial immune funct
Timed Senolytic Therapy Eliminates p16^Ink4a/p21^Cip1-Senesc 0.587 neuroinflammation What molecular mechanisms drive the tran
TREM2-SIRT1 Metabolic Senescence Circuit in Microglial Aging 0.587 neurodegeneration Gene expression changes in aging mouse b
TREM2-Mediated Astrocyte-Microglia Cross-Talk in Neurodegene 0.585 neurodegeneration Gene expression changes in aging mouse b
TREM2-Mediated Astrocyte-Microglia Cross-Talk in Neurodegene 0.580 neurodegeneration Gene expression changes in aging mouse b
TREM2-Mediated Cholesterol Dysregulation in Microglial Senes 0.574 neurodegeneration Gene expression changes in aging mouse b
CYP46A1 Gene Therapy for Age-Related TREM2-Mediated Microgli 0.569 neurodegeneration Lipid raft composition changes in synapt
Targeted Butyrate Supplementation for Microglial Phenotype M 0.559 neurodegeneration What are the mechanisms by which gut mic
Senescent Microglia Resolution via Maresins-Senolytics Combi 0.552 neurodegeneration Neuroinflammation resolution mechanisms
Vascular-Glial Interface Restoration 0.544 neurodegeneration Cell type vulnerability in Alzheimers Di
ABCA7-TREM2 Co-Targeting for Microglial Lipid Handling 0.538 neurodegeneration Why does the V1613M variant reduce amylo
Microglial-Mediated Tau Clearance Dysfunction via TREM2 Sign 0.533 neuroscience Circuit-level neural dynamics in neurode
TREM2-Mediated Microglial Dysfunction Disrupts Perivascular 0.527 neuroscience Circuit-level neural dynamics in neurode
Microglial TREM2-Complement Axis Modulation 0.527 neurodegeneration Cell type vulnerability in Alzheimer's D

Mentioning Analyses (30)

Scientific analyses that reference this entity

What molecular mechanisms mediate SPP1-induced microglial phagocytic activation

neuroinflammation | 2026-04-15 | 1 hypotheses Top: 0.650

What is the temporal sequence of TREM2 signaling transition from protective to i

neuroimmunology | 2026-04-15 | 2 hypotheses Top: 0.674

How does SYNGAP1, a 'synaptic' protein, function in pre-synaptic radial glia cel

neurodevelopment | 2026-04-15 | 1 hypotheses Top: 0.576

What molecular mechanisms enable Gal3 to enhance tau fibrillation upon binding t

neurodegeneration | 2026-04-15 | 0 hypotheses

What signals trigger microglia to specifically recognize and phagocytose LC axon

neuroinflammation | 2026-04-14 | 0 hypotheses

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Microglia-Mediated Neuroinflammation: A Potential Target for the Treatment of Ca [PMID:35642214] Wang M, Pan W, Xu Y, Zhang J, Wan J, Jia J Inflamm Res 2022 1
TREM2, microglia, and Alzheimer's disease. [PMID:33516818] Qin Q, Teng Z, Liu C, Li Q, Yin Y, Tang Mech Ageing Dev 2021 1
Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2- [PMID:31932797] Zhou Y, Song WM, Andhey PS, Swain A, Lev Nat Med 2020 1
TREM2 Maintains Microglial Metabolic Fitness in Alzheimer's Disease. [PMID:28802038] Ulland TK, Song WM, Huang SC, Ulrich JD, Cell 2017 1
The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Mic [PMID:28930663] Krasemann S, Madore C, Cialic R, Baufeld Immunity 2017 1
Modulating LRP1 Pathways in Alzheimer's Disease: Mechanistic Insights and Emergi [PMID:41772271] Mushtaq T, Hameed H, Khan MA, Tariq U, H Molecular neurobiology 2026 0
Macrophagic Sclerostin Loop2-ApoER2 Interaction Required by Sclerostin for Cardi [PMID:41276911] Wang L, Tao X, Zhang N, Yang X, Jiang H Adv Sci (Weinh) 2026 0
APOE Genotype Modulates the Relationship of Stroke With Dementia Risk: Associati [PMID:41404739] Zhang CH, Huang LY, Feng YG, Tan CC, Tan J Am Heart Assoc 2026 0
High- and Low-Fat Dairy Consumption and Long-Term Risk of Dementia: Evidence Fro [PMID:41406402] Du Y, Borné Y, Samuelsson J, Glans I, Hu Neurology 2026 0
Prime Editing of Alzheimer's Disease High-Risk APOE4 Allele by Brain-Directed Ad [PMID:41449667] Günaydin C, Hackett NR, Wakim V, Sondhi Hum Gene Ther 2026 0
The role of astrocytes in Alzheimer's disease: Pathophysiology, biomarkers, and [PMID:41527736] Abedin MJ, Kastanenka KV J Alzheimers Dis 2026 0
Endothelial TBK1 Deficiency Inhibits Endothelial-to-Mesenchymal Transition and A [PMID:41685426] Pu Y, Dong P, He L, Huang J, Wu Y et al. Circ Res 2026 0
Lipidome and proteome of astrocyte and microglia ApoE lipoprotein reveal differe [PMID:41692246] Strickland MR, Wang Z, Golden LR, Wang H J Lipid Res 2026 0
Protective mutations associated with APOE in Alzheimer's disease. [PMID:41703264] Ma Y, Li Y, Wu G, Liu L, Tian M et al. Mol Psychiatry 2026 0
HTRA1 and Brain Disorders: A Balancing Act Across Neurodegeneration and Repair. [PMID:41932381] Hjæresen S, Gramkow ET, Zhang M, Svennin Prog Neurobiol 2026 0
Trajectories of frailty, grip strength and gait speed preceding dementia: a nest [PMID:41936045] Wu Z, Phyo AZZ, Cribb L, Vishwanath S, O Age Ageing 2026 0
Amyloid-related imaging abnormalities in Japanese patients with Alzheimer's dise [PMID:41936348] Shimasaki R, Kurihara M, Bannai T, Hatan J Prev Alzheimers Dis 2026 0
Apolipoprotein E proteotyping as a valid alternative to genotyping in clinical p [PMID:41940854] Alcalá Ramírez Del Puerto JM, Ortega-Mad J Alzheimers Dis 2026 0
Opposing patterns of blood-brain barrier permeability and Alzheimer's disease bi [PMID:41942760] Bernocchi F, Bonomi CG, Poli M, Di Donna Neurological sciences : offici 2026 0
Structural MRI phenotyping in Alzheimer's disease: Comparison of visual rating s [PMID:41943971] Aracki-Trenkic A, Živanović M, Milošević Biomol Biomed 2026 0